BAG3: A new therapeutic target of human cancers?

Histology and Histopathology

Volumn 27, Issue 3, 2012, Pages 257-261

  Zhu, Huayuan ^a   Liu, P ^a   Li, Jianyong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adhesin; Apoptosis; Cancer; Leukemia; Migration

Indexed keywords

ANTINEOPLASTIC AGENT; BAG3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL; APOPTOSIS; CANCER INVASION; CELL ADHESION; CELL MOTION; CELL SURVIVAL; DRUG RESISTANCE; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE THERAPY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 84863283179     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Ammirante M., Rosati A., Arra C., Basile A., Falco A., Festa M., Pascale M., d'Avenia M., Marzullo L., Belisario M.A., De Marco M., Barbieri A., Giudice A., Chiappetta G., Vuttariello E., Monaco M., Bonelli P., Salvatore G., Di Benedetto M., Deshmane S.L., Khalili K., Turco M.C. and Leone A. (2010). IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc. Natl. Acad. Sci. USA 107, 7497-7502.
2. Antoku K., Maser R.S., Scully W.J. Jr, Delach S.M. and Johnson D.E. (2001). Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. Biochem. Biophys. Res. Commun. 286, 1003-1010.
3. Bonelli P., Petrella A., Rosati A., Romano M.F., Lerose R., Pagliuca M.G., Amelio T., Festa M., Martire G., Venuta S., Turco M.C. and Leone A. (2004). BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18, 358-360.
4. Brabek J., Constancio S.S., Siesser P.F., Shin N.Y., Pozzi A. and Hanks S.K. (2005). Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol. Cancer. Res. 3, 307-315.
5. Briknarova K., Takayama S., Brive L., Havert M.L., Knee D.A., Velasco J., Homma S., Cabezas E., Stuart J., Hoyt D.W., Satterthwait A.C., Llinas M., Reed J.C. and Ely K.R. (2001). Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat. Struct. Biol. 8, 349-352.
6. Briknarova K., Takayama S., Homma S., Baker K., Cabezas E., Hoyt D.W., Li Z., Satterthwait A.C. and Ely K.R. (2002). BAG4/SODD protein contains a short BAG domain. J. Biol. Chem. 277, 31172-31178.
7. Carra S., Seguin S.J. and Landry J. (2008). HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy 4, 237-239.
8. Cesaro E., Montano G., Rosati A., Crescitelli R., Izzo P., Turco M.C. and Costanzo P. (2010). WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia 24, 1204-1206.
9. Chen H.Y., Liu P., Sun M., Wu L.Y., Zhu H.Y., Qiao C., Dong H.J., Zhu D.X., Xu W. and Li J.Y. (2010). Bag3 gene expression in chronic lymphocytic leukemia and its association with patients' prognosis. Zhongguo. Shi.Yan. Xue. Ye. Xue. Za. Zhi. 18, 838-842.
10. Chiappetta G., Ammirante M., Basile A., Rosati A., Festa M., Monaco M., Vuttariello E., Pasquinelli R., Arra C., Zerilli M., Todaro M., Stassi G., Pezzullo L., Gentilella A., Tosco A., Pascale M., Marzullo L., Belisario M.A., Turco M.C. and Leone A. (2007). The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Clin. Endocrinol. Metab. 92, 1159-1163.
11. Doong H., Vrailas A. and Kohn E.C. (2002). What's in the 'BAG'?--A functional domain analysis of the BAG-family proteins. Cancer Lett. 188, 25-32.
12. Du Z.X., Meng X., Zhang H.Y., Guan Y. and Wang H.Q. (2008). Caspase-dependent cleavage of BAG3 in proteasome inhibitorsinduced apoptosis in thyroid cancer cells. Biochem. Biophys. Res. Commun. 369, 894-898.
13. Du Z.X., Zhang H.Y., Meng X., Gao Y.Y., Zou R.L., Liu B.Q., Guan Y. and Wang H.Q. (2009). Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1. J. Cell. Physiol. 218, 631-637.
14. Fuchs M., Poirier D.J., Seguin S.J., Lambert H., Carra S., Charette S.J. and Landry J. (2010). Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem. J. 425, 245-255.
15. Gamerdinger M., Hajieva P., Kaya A.M., Wolfrum U., Hartl F.U. and Behl C. (2009). Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 28, 889-901.
16. Hishiya A., Salman M.N., Carra S., Kampinga H.H. and Takayama S. (2011). BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity. PLoS. One 6, e16828.
17. Homma S., Iwasaki M., Shelton G.D., Engvall E., Reed J.C. and Takayama S. (2006). BAG3 deficiency results in fulminant myopathy and early lethality. Am. J. Pathol. 169, 761-773.
18. Iwasaki M., Homma S., Hishiya A., Dolezal S.J., Reed J.C. and Takayama S. (2007). BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer. Res. 67, 10252-10259.
19. Iwasaki M., Tanaka R., Hishiya A., Homma S., Reed J.C. and Takayama S. (2010). BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion. Biochem. Biophys. Res. Commun. 400, 413-418.
20. Jacobs A.T. and Marnett L.J. (2009). HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J. Biol. Chem. 284, 9176-9183.
21. Karabulut B., Karaca B., Varol U., Muslu U., Cakar B., Atmaca H., Kisim A., Uzunoglu S. and Uslu R. (2010). Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. J. Exp. Clin. Cancer. Res. 29, 102.
22. Kassis J.N., Guancial E.A., Doong H., Virador V. and Kohn E.C. (2006). CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp. Cell Res. 312, 2962-2971.
23. Kassis J.N., Virador V.M., Guancial E.A., Kimm D., Ho A.S., Mishra M., Chuang E.Y., Cook J., Gius D. and Kohn E.C. (2009). Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J. Pathol. 218, 495-504.
24. Kohn E.C., Felder C.C., Jacobs W., Holmes K.A., Day A., Freer R. and Liotta L.A. (1994). Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer. Res. 54, 935-942.
25. Lee J.H., Takahashi T., Yasuhara N., Inazawa J., Kamada S. and Tsujimoto Y. (1999). Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18, 6183-6190.
26. Liao Q., Ozawa F., Friess H., Zimmermann A., Takayama S., Reed J.C., Kleeff J. and Buchler M.W. (2001). The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett. 503, 151-157.
27. Liu P., Xu B., Li J. and Lu H. (2009). BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett. 583, 401-406.
28. Pagliuca M.G., Lerose R., Cigliano S. and Leone A. (2003). Regulation by heavy metals and temperature of the human BAG-3 gene, a modulator of Hsp70 activity. FEBS Lett. 541, 11-15.
29. Romano M.F., Festa M., Pagliuca G., Lerose R., Bisogni R., Chiurazzi F., Storti G., Volpe S., Venuta S., Turco M.C. and Leone A. (2003a). BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell. Death Differ. 10, 383-385.
30. Romano M.F., Festa M., Petrella A., Rosati A., Pascale M., Bisogni R., Poggi V., Kohn E.C., Venuta S., Turco M.C. and Leone A. (2003b). BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol. Ther. 2, 508-510.
31. Rosati A., Ammirante M., Gentilella A., Basile A., Festa M., Pascale M., Marzullo L., Belisario M.A., Tosco A., Franceschelli S., Moltedo O., Pagliuca G., Lerose R. and Turco M.C. (2007). Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int. J. Biochem. Cell Biol. 39, 1337-1342.
32. Selcen D., Muntoni F., Burton B.K., Pegoraro E., Sewry C., Bite A.V. and Engel A.G. (2009). Mutation in BAG3 causes severe dominantchildhood muscular dystrophy. Ann. Neurol. 65, 83-89.
33. Sondermann H., Scheufler C., Schneider C., Hohfeld J., Hartl F.U. and Moarefi I. (2001). Structure of a Bag/Hsc70 complex: convergent functional evolution of Hsp70 nucleotide exchange factors. Science 291, 1553-1557.
34. Song J., Takeda M. and Morimoto R.I. (2001). Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat. Cell. Biol. 3, 276-282.
35. Staibano S., Mascolo M., Di Benedetto M., Vecchione M.L., Ilardi G., Di Lorenzo G., Autorino R., Salerno V., Morena A., Rocco A., Turco M.C. and Morelli E. (2010). BAG3 protein delocalisation in prostate carcinoma. Tumour. Biol. 31, 461-469.
36. Takayama S. and Reed J.C. (2001). Molecular chaperone targeting and regulation by BAG family proteins. Nat. Cell. Biol. 3, E237-241.
37. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J.A. and Reed J.C. (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80, 279-284.
38. Takayama S., Xie Z. and Reed J.C. (1999). An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 274, 781-786.
39. Valdez B.C., Murray D., Ramdas L., de Lima M., Jones R., Kornblau S., Betancourt D., Li Y., Champlin R.E. and Andersson B.S. (2008). Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk. Res. 32, 1684-1697.
40. Vidal M., Gigoux V. and Garbay C. (2001). SH2 and SH3 domains as targets for anti-proliferative agents. Crit. Rev. Oncol. Hematol. 40, 175-186.
41. Virador V.M., Davidson B., Czechowicz J., Mai A., Kassis J. and Kohn E.C. (2009). The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome. PLoS One 4, e5136.
42. Wang H.Q., Liu H.M., Zhang H.Y., Guan Y. and Du Z.X. (2008). Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem. Biophys. Res. Commun. 365, 381-385.
43. Wang H.Q., Liu B.Q., Gao Y.Y., Meng X., Guan Y., Zhang H.Y. and Du Z.X. (2009). Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br. J. Pharmacol. 158, 1405-1412.
44. Youn D.Y., Lee D.H., Lim M.H., Yoon J.S., Lim J.H., Jung S.E., Yeum C.E., Park C.W., Youn H.J., Lee J.S., Lee S.B., Ikawa M., Okabe M., Tsujimoto Y. and Lee J.H. (2008). Bis deficiency results in early lethality with metabolic deterioration and involution of spleen and thymus. Am. J. Physiol. Endocrinol. Metab. 295, E1349-1357.